Apomorphine (emetic)

Apomorphine is a potent dopamine receptor agonist that serves as the gold standard emetic agent in veterinary emergency medicine for dogs. This medication works by stimulating the chemoreceptor trigger zone in the brain, which rapidly induces vomiting to expel recently ingested toxic substances from the stomach. Apomorphine has been a cornerstone of canine toxicology treatment for decades due to its reliable and predictable emetic effects when administered properly by trained veterinary professionals.

The mechanism of action of apomorphine involves direct stimulation of dopamine D2 receptors located in the chemoreceptor trigger zone of the medulla oblongata. This area of the brain sits outside the blood-brain barrier, making it responsive to circulating substances and allowing apomorphine to trigger the vomiting reflex efficiently. The drug typically induces emesis within three to six minutes of administration, making it invaluable in time-sensitive poisoning situations where rapid stomach evacuation is critical for patient survival.

Apomorphine is available in two primary formulations for veterinary use: an injectable solution administered subcutaneously or intramuscularly, and a tablet formulation designed for conjunctival (eye) administration. The conjunctival route involves placing a small tablet portion under the eyelid, where the drug absorbs through the mucous membranes. This ocular route offers the advantage of easy reversal by simply removing the tablet and rinsing the eye once adequate vomiting has occurred. Both formulations provide rapid onset of action, though the injectable form may produce slightly faster results in some cases.

Apomorphine is considered safe and highly effective when administered under proper veterinary supervision in appropriate clinical situations. However, this medication should never be administered at home or without professional guidance, as improper use can lead to serious complications. The decision to induce vomiting must be made by a veterinarian who can assess whether emesis is appropriate based on the substance ingested, the time since ingestion, and the patient's overall condition. Certain toxic substances and clinical situations contraindicate induced vomiting, making professional evaluation essential before apomorphine administration.

The primary indication for apomorphine in dogs is the emergency induction of vomiting following recent ingestion of toxic substances. This medication is most effective when administered within one to two hours of toxin ingestion, before the substance has passed from the stomach into the small intestine where it can no longer be retrieved through emesis. Common poisoning scenarios where apomorphine proves lifesaving include ingestion of chocolate, xylitol-containing products, certain human medications, rodenticides, and various household chemicals that pose significant toxicity risks to dogs.

Apomorphine excels in situations requiring rapid gastric decontamination where the ingested substance is known to be dangerous but has not yet been fully absorbed. Veterinarians consider this drug particularly valuable for treating chocolate toxicosis, which remains one of the most common poisoning presentations in emergency veterinary practice. The drug effectively evacuates chocolate from the stomach before the theobromine and caffeine can reach toxic blood levels. Similarly, apomorphine serves as a first-line intervention for dogs that have ingested grapes, raisins, certain mushrooms, or prescription medications belonging to household members.

Beyond acute poisoning emergencies, apomorphine may occasionally be used in diagnostic situations where examination of stomach contents provides valuable clinical information. Some veterinary facilities utilize controlled emesis to retrieve foreign objects that a dog has recently swallowed, provided the object is not sharp, caustic, or likely to cause additional damage during regurgitation. This application requires careful professional judgment regarding the size, shape, and composition of the ingested object.

Apomorphine represents the emetic of choice in most canine poisoning situations because of its superior efficacy compared to other available options. Hydrogen peroxide, while accessible to pet owners, produces less reliable emesis and can cause gastric irritation. Apomorphine's mechanism of action through central dopamine receptor stimulation provides more consistent and complete stomach evacuation in most patients. The drug works independently of gastric contents and produces effective emesis even in dogs with relatively empty stomachs.

Veterinary professionals select apomorphine specifically when rapid, reliable emesis is required and no contraindications exist. The medication is not appropriate for every poisoning situation, and veterinarians must evaluate each case individually. Factors influencing the decision to use apomorphine include the specific toxin involved, the estimated amount ingested, the time elapsed since ingestion, the dog's level of consciousness and neurological status, and any pre-existing health conditions that might increase procedure risks.

Apomorphine administration is exclusively performed by veterinary professionals in clinical settings due to the specialized knowledge required for safe and effective use. The dosing protocol varies depending on the administration route chosen, with both injectable and conjunctival methods producing reliable emesis when properly executed. Veterinarians determine the exact dose based on the individual patient's weight, overall health status, and the urgency of the clinical situation, always using the minimum effective dose to achieve adequate stomach evacuation.

The injectable formulation of apomorphine is typically administered at a dose ranging from 0.03 to 0.04 milligrams per kilogram of body weight when given intravenously, or 0.04 to 0.08 milligrams per kilogram when administered subcutaneously or intramuscularly. The intravenous route produces the fastest onset but requires precise dilution and careful administration. Subcutaneous injection remains the most common route in many veterinary practices, offering reliable absorption with slightly more forgiving dosing precision. Vomiting typically begins within two to five minutes following injection, with most dogs experiencing several productive episodes over a ten to fifteen minute period.

The conjunctival tablet administration method involves placing a portion of an apomorphine tablet, typically one-quarter to one-half of a 6 mg tablet, directly into the conjunctival sac beneath the lower eyelid. The tablet dissolves and absorbs through the conjunctival mucosa, stimulating the chemoreceptor trigger zone and inducing emesis. This route offers the distinct advantage of reversibility; once adequate vomiting has occurred, the veterinary team can remove any remaining tablet material and rinse the eye with sterile saline to halt further drug absorption and prevent excessive emesis or prolonged sedation.

The duration of apomorphine's emetic effect depends on the administration route and dose. With conjunctival administration, effects typically subside within five to ten minutes after tablet removal and eye rinsing. Injectable apomorphine may produce a slightly longer duration of action since the drug cannot be physically removed once administered. Most dogs complete their vomiting episodes within fifteen to twenty minutes regardless of administration route, though some patients may experience prolonged effects requiring supportive care.

If initial apomorphine administration fails to produce adequate emesis, veterinarians must carefully evaluate whether repeat dosing is appropriate. Repeat dosing carries increased risks of excessive central nervous system depression and is generally avoided unless absolutely necessary. The response to apomorphine can be affected by the dog's stomach contents, concurrent medications, and the presence of certain toxins that may suppress the vomiting reflex. In cases where apomorphine proves ineffective, alternative decontamination methods such as gastric lavage may be considered.

Following apomorphine administration and successful emesis, veterinary teams typically monitor patients for potential complications including prolonged sedation, excessive salivation, and respiratory depression. Many dogs experience transient sedation as a side effect of the dopamine receptor stimulation. Activated charcoal administration often follows successful emesis to bind any remaining toxin in the gastrointestinal tract, though the timing and necessity depend on the specific substance ingested.

Apomorphine is generally well-tolerated when administered appropriately by veterinary professionals, though several predictable side effects accompany its use. Understanding these effects helps veterinary teams provide appropriate monitoring and supportive care during and after the emesis induction procedure. Most side effects are transient and resolve without intervention as the drug is metabolized and eliminated from the body.

The most commonly observed side effects of apomorphine include sedation, excessive salivation, and restlessness during the initial minutes following administration. Sedation represents a direct consequence of dopamine receptor stimulation and varies in intensity among individual patients. Some dogs become notably drowsy and may need support to remain in a safe position during vomiting, while others show minimal sedation. Hypersalivation occurs frequently and may precede the onset of vomiting, serving as a useful indicator that the drug is taking effect. Mild restlessness or anxiety sometimes accompanies the nausea phase before active emesis begins.

Moderate side effects that may occur include protracted vomiting, prolonged sedation extending beyond thirty minutes, and cardiovascular effects including changes in heart rate and blood pressure. Some dogs experience more severe or prolonged vomiting than desired, which can lead to dehydration or electrolyte imbalances if extensive. Respiratory depression represents a concern with higher doses or particularly sensitive patients, requiring monitoring of respiratory rate and effort during the recovery period. The conjunctival administration route may cause temporary eye irritation, redness, or excessive tearing that typically resolves after the tablet is removed and the eye is rinsed.

Serious side effects, while uncommon with proper dosing, require immediate veterinary attention. Severe respiratory depression can occur in sensitive individuals or with excessive dosing, manifesting as notably slowed breathing or labored respiratory effort. Profound sedation rendering the dog unresponsive or difficult to rouse indicates excessive central nervous system depression. Aspiration pneumonia represents a potential complication if a heavily sedated dog inhales vomited material; this risk underscores the importance of proper positioning and monitoring during the procedure. Cardiac arrhythmias have been reported rarely and typically occur in patients with pre-existing heart conditions.

Rare side effects and idiosyncratic reactions include allergic responses, paradoxical excitement, and prolonged effects in individual patients with unusual drug sensitivity. Dogs with the MDR1 gene mutation may experience enhanced effects from apomorphine due to altered drug handling at the blood-brain barrier. Veterinary teams should be prepared with appropriate reversal agents and supportive care equipment when administering this medication. Overall, the risk-benefit analysis strongly favors apomorphine use in appropriate poisoning situations, as the potential consequences of untreated toxin absorption typically far outweigh the manageable risks of properly supervised emesis induction.

Apomorphine carries several important contraindications that veterinary professionals must evaluate before administration. Using this medication in inappropriate circumstances can cause serious harm, potentially worse than the original poisoning concern. Understanding when not to induce vomiting is as crucial as knowing when emesis is indicated, making thorough patient assessment essential before apomorphine use.

The most critical contraindication involves ingestion of caustic or corrosive substances, including strong acids, alkalis, or petroleum distillates. Inducing vomiting after ingestion of drain cleaners, oven cleaners, battery acid, or similar corrosive materials causes the substance to pass through the esophagus a second time, dramatically increasing the risk of severe chemical burns and esophageal perforation. Petroleum products like gasoline, kerosene, and certain solvents pose aspiration risks; these volatile substances can cause severe chemical pneumonitis if inhaled into the lungs during vomiting.

Apomorphine should not be administered to dogs with compromised consciousness, including those showing seizure activity, severe lethargy, stupor, or coma. Patients with diminished protective reflexes cannot adequately protect their airways during vomiting, creating substantial aspiration pneumonia risk. Similarly, dogs experiencing active seizures or those with recent head trauma should not receive emetic therapy. If a toxin causes rapid neurological deterioration, the window for safe emesis may close quickly, requiring alternative decontamination approaches.

Pre-existing medical conditions may contraindicate apomorphine use in certain patients. Dogs with known cardiac arrhythmias or severe cardiovascular disease may experience dangerous cardiac effects from dopamine receptor stimulation. Respiratory compromise from any cause increases the risks associated with the sedation and potential respiratory depression that apomorphine produces. Patients with megaesophagus or other esophageal disorders face elevated aspiration risks during any vomiting episode. Severe debilitation or shock states represent relative contraindications requiring careful risk-benefit assessment.

Timing considerations also influence apomorphine's appropriateness. If more than two to four hours have elapsed since toxin ingestion, inducing vomiting may provide little benefit as stomach contents have likely passed into the small intestine. Sharp or pointed foreign objects should not be retrieved through induced emesis due to perforation and laceration risks during regurgitation. Additionally, apomorphine should be avoided in pregnant dogs near term due to potential effects on labor. Veterinarians must gather complete patient histories and assess each situation individually, recognizing that the decision not to induce vomiting sometimes represents the safest course of action.

Understanding potential drug interactions with apomorphine helps veterinary professionals anticipate complications and modify their treatment approach when necessary. Because apomorphine is typically administered in emergency situations to patients with unknown medication histories, awareness of possible interactions helps guide patient monitoring and supportive care decisions during and after the emesis procedure.

Apomorphine's emetic effects can be antagonized or blocked by several medication classes. Phenothiazine antiemetics such as chlorpromazine and prochlorperazine work by blocking dopamine receptors, directly opposing apomorphine's mechanism of action and potentially rendering the emetic ineffective. Dogs that have recently received antiemetic medications may show reduced or absent response to apomorphine. Similarly, metoclopramide, while sometimes classified as a prokinetic agent, has dopamine-blocking properties that can interfere with apomorphine-induced emesis. Ondansetron and other serotonin receptor antagonist antiemetics have less direct interaction but may still modify the emetic response in some patients.

Central nervous system depressants can potentiate apomorphine's sedative effects, increasing the risk of excessive sedation and respiratory depression. This category includes opioid pain medications, benzodiazepines, barbiturates, and various anesthetic agents. Dogs that have ingested sedating substances as part of their poisoning presentation may experience enhanced CNS depression when apomorphine is administered. This interaction requires heightened monitoring and readiness to provide respiratory support if needed. Conversely, if the toxin ingested has stimulant properties, the clinical picture may be complicated by opposing drug effects.

Certain cardiovascular medications interact with apomorphine's effects on heart rate and blood pressure. Beta-blocking drugs may alter the cardiovascular response to dopamine receptor stimulation. Antihypertensive medications may potentiate apomorphine's blood pressure-lowering effects in some patients. Dogs receiving cardiac glycosides such as digoxin require careful monitoring, as vomiting-induced electrolyte shifts can affect digitalis toxicity risk.

Veterinary teams should obtain thorough medication histories whenever possible before administering apomorphine, though emergency situations may preclude complete information gathering. When interaction risks exist, enhanced monitoring protocols help identify complications early. Having naloxone available is prudent since it can partially reverse apomorphine's effects if excessive sedation or respiratory depression occurs. The dopamine antagonist properties of naloxone make it a useful reversal option in apomorphine overdose situations. Documentation of all medications administered and patient responses supports optimal ongoing care and helps identify interaction patterns that inform future treatment decisions.

Apomorphine administration requires adherence to important precautions that maximize safety and treatment efficacy. This medication should only be administered in veterinary clinical settings where appropriate monitoring equipment, trained personnel, and emergency support capabilities are immediately available. The controlled environment of a veterinary facility allows proper response to any complications that may arise during the emesis procedure.

Patient positioning during and after apomorphine administration significantly affects aspiration risk. Dogs should be positioned with their heads lower than their bodies during active vomiting to promote expulsion rather than aspiration of gastric contents. Heavily sedated patients require particular attention to airway protection. Veterinary staff should never leave a patient unattended during the active emesis period, and continued monitoring following vomiting completion ensures recognition of delayed complications.

Breed-specific considerations warrant attention when administering apomorphine. Brachycephalic breeds such as Bulldogs, Pugs, and Boston Terriers face inherently increased respiratory compromise and aspiration risks due to their anatomical conformation. These breeds may experience more pronounced respiratory effects from apomorphine's sedative properties and require enhanced monitoring. Dogs with the MDR1 gene mutation, common in Collies, Australian Shepherds, and related herding breeds, may show increased sensitivity to apomorphine's central nervous system effects due to altered drug distribution across the blood-brain barrier.

Environmental and handling precautions protect both patients and veterinary personnel. The conjunctival tablet formulation should be handled with gloves to prevent accidental human exposure, as apomorphine can be absorbed through skin and mucous membranes. Proper storage maintains drug stability and effectiveness. Emergency supplies including oxygen supplementation equipment, suction capability, and reversal agents should be immediately accessible whenever apomorphine is administered.

Special population considerations include geriatric patients, who may experience prolonged sedation and slower recovery from apomorphine administration. Very young puppies have immature drug metabolism capabilities and may show enhanced or prolonged effects. Dogs with hepatic impairment may metabolize apomorphine more slowly, potentially extending its duration of action. Renal dysfunction, while not a primary elimination pathway for apomorphine, may affect overall patient stability during the procedure. Pregnant dogs should generally not receive apomorphine except in life-threatening poisoning situations where the benefits clearly outweigh risks to the developing puppies.

Proper storage of apomorphine maintains the medication's stability and ensures reliable efficacy when needed for emergency situations. The injectable formulation requires protection from light, as apomorphine is photosensitive and will degrade when exposed to ultraviolet radiation. Solutions should be stored in their original light-protective containers or wrapped in aluminum foil if transfer to another container is necessary. Room temperature storage between 15 and 30 degrees Celsius (59 to 86 degrees Fahrenheit) is appropriate for most formulations, though specific manufacturer guidelines should be followed.

The conjunctival tablet formulation requires similar light protection and should remain in its original packaging until use. These tablets are hygroscopic, meaning they absorb moisture from the air, which can affect dissolution characteristics and drug stability. Maintaining tablets in their sealed packaging until immediately before administration helps ensure consistent performance. Opened packages should be used promptly rather than stored for extended periods. Veterinary facilities should monitor expiration dates and rotate stock to ensure fresh medication is available when emergencies occur.

Apomorphine solutions may show color changes as they degrade, turning green due to oxidation. Any discoloration indicates drug degradation and the solution should not be used. Even solutions that appear normal should be discarded if stored beyond manufacturer-specified dating. The critical nature of emergency medications makes reliable potency essential; using degraded medication in a poisoning emergency could result in treatment failure with potentially fatal consequences.

Safe handling practices protect veterinary personnel from accidental exposure. Apomorphine can be absorbed through intact skin and mucous membranes, potentially causing nausea and vomiting in exposed humans. Wearing appropriate personal protective equipment including gloves during preparation and administration minimizes exposure risk. Any spills should be cleaned promptly using appropriate protocols. Sharps disposal for injectable formulations follows standard veterinary practice guidelines. Unused medication and expired stock should be disposed of through appropriate pharmaceutical waste channels rather than standard trash or drain disposal.

While apomorphine is effective across all dog breeds, certain breed-specific factors influence administration protocols and monitoring requirements. Understanding these considerations helps veterinary professionals optimize treatment safety and effectiveness for individual patients. Most dogs respond predictably to appropriate apomorphine doses, but awareness of breed-related sensitivities supports best practices in emergency care.

The MDR1 (ABCB1) gene mutation significantly affects drug handling in affected breeds and may influence apomorphine response. Breeds with high MDR1 mutation prevalence include Collies (approximately 70% affected), Australian Shepherds, Shetland Sheepdogs, Old English Sheepdogs, English Shepherds, Border Collies, and mixed breeds with herding dog ancestry. This mutation affects the blood-brain barrier's ability to exclude certain drugs from the central nervous system, potentially resulting in enhanced drug effects. Dogs with known or suspected MDR1 mutation status may show increased sensitivity to apomorphine's sedative effects, warranting conservative dosing and enhanced monitoring.

Brachycephalic breeds present unique challenges for emesis induction due to their compromised upper airway anatomy. Breeds including Bulldogs, French Bulldogs, Pugs, Boston Terriers, Pekingese, and Shih Tzus have shortened skulls, narrowed nostrils, elongated soft palates, and other conformational abnormalities that increase respiratory effort and aspiration risk. These patients require particularly careful positioning during vomiting and enhanced respiratory monitoring throughout the procedure. The sedation produced by apomorphine may further compromise already marginal respiratory function in these breeds, necessitating readiness for oxygen supplementation or other respiratory support.

Size-related considerations affect all aspects of apomorphine use, from dosing precision to aspiration risk management. Giant breeds such as Great Danes, Saint Bernards, Irish Wolfhounds, and Mastiffs produce larger volumes of vomitus, requiring appropriate positioning and cleanup preparations. Toy and miniature breeds including Chihuahuas, Yorkshire Terriers, Maltese, and Toy Poodles require precise weight measurement and careful dose calculation to avoid excessive medication. The relatively smaller safety margin in tiny patients makes accurate dosing critically important.

Age-related factors intersect with breed considerations in many patients. Pediatric patients of any breed have immature drug metabolism pathways and may show prolonged or enhanced effects from apomorphine. Geriatric dogs, particularly those from breeds predisposed to age-related organ dysfunction, may require dose modifications and extended monitoring periods. The veterinarian's assessment of each individual patient's condition, regardless of breed, ultimately guides treatment decisions in emergency situations where apomorphine use is considered.

Several other medications serve emetic or related functions in veterinary emergency medicine, providing alternatives or adjuncts to apomorphine depending on clinical circumstances. Understanding the range of available options helps veterinary professionals select the most appropriate intervention for each patient and situation. While apomorphine remains the gold standard emetic for dogs, knowledge of alternatives proves valuable when apomorphine is unavailable, contraindicated, or ineffective.

Hydrogen peroxide (3% solution) represents the most commonly used home emetic for dogs, though its use is generally discouraged without veterinary guidance. When administered orally at appropriate doses, hydrogen peroxide causes gastric irritation that triggers vomiting through a local mechanism rather than central chemoreceptor stimulation. This medication is less reliable than apomorphine, with emesis occurring in approximately 50-90% of dogs depending on various factors. Hydrogen peroxide can cause gastric irritation and rare cases of gastric ulceration, making it less ideal than apomorphine when the latter is available. However, its accessibility makes it a potential first-aid measure when immediate veterinary care is delayed.

Clevor (ropinirole ophthalmic solution) represents a newer alternative to apomorphine for emesis induction in dogs. This dopamine agonist is administered as eye drops and provides reliable emesis through a similar central mechanism. Ropinirole may offer advantages in terms of ease of administration and predictability of onset. Its availability provides veterinary practices with an additional tool for emergency decontamination. The medication received FDA approval for veterinary use and has become increasingly adopted in emergency veterinary practice.

Adjunct therapies commonly follow successful emesis induction regardless of which emetic agent was used. Activated charcoal administration helps bind remaining toxin in the gastrointestinal tract, reducing ongoing absorption. Specific antidotes may be indicated depending on the toxin involved, working alongside gastrointestinal decontamination to minimize poisoning effects. Intravenous fluid therapy supports patients showing dehydration or cardiovascular effects from either the toxin or the treatment process. Veterinary professionals select from these various tools based on the specific clinical scenario, always prioritizing patient safety and optimal outcomes in these challenging emergency situations.